Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZQT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,765
Award facts
- Contract value 100% obligated
- $14,764.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 12, 2026, provides RINVOQ ER 30 mg tablets (30-count units) to the Defense Logistics Agency through AmerisourceBergen Drug Corp, the pharmaceutical distribution subsidiary of Cencora, Inc. The contract carries a firm fixed price ceiling value of $14.76K with an ultimate completion date of January 13, 2026, and represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the awardee and point of performance for this order, leveraging its established relationship with the DLA's medical supply operations.
This delivery order falls under Cencora's significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99M through December 2031. That IDC serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs globally, including the Defense Health Agency and other federal medical institutions. The non-set-aside designation indicates this award was competitively procured, consistent with AmerisourceBergen's demonstrated capability to fulfill federal pharmaceutical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F4ZQT?
SPE2DR26F4ZQT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F4ZQT worth?
The government has obligated $14,765 on SPE2DR26F4ZQT.
Is contract SPE2DR26F4ZQT an order under another contract?
Yes. SPE2DR26F4ZQT is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZQT competed?
The extent of competition for SPE2DR26F4ZQT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award